RECRUITING

Remote Monitoring and Detecting of Tardive Dyskinesia for Improving Patient Outcomes

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The study is being conducted to validate the feasibility of remote assessment of Tardive Dyskinesia.

Official Title

Remote Monitoring and Detecting of Tardive Dyskinesia for Improving Patient Outcomes

Quick Facts

Study Start:2023-05-30
Study Completion:2024-12-31
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT06011408

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. 1. Prescribed and taking an antipsychotic medication for 90-days or longer.
  2. 2. Tardive Dyskinesia symptoms if present are not from Parkinsons, Tourette's syndrome, Huntington disease.
  3. 3. Signed an informed consent.
  4. 4. Speaks English fluently.
  1. 1. Suffered a moderate or severe head injury in the last year;
  2. 2. History of a learning disorder or developmental disability that would inhibit a patient from completing the TD protocol.
  3. 3. Severe visual impairment that is cannot be corrected by glasses or contacts.

Contacts and Locations

Study Contact

Anthony Sterns, Ph.D.
CONTACT
3306066675
asterns@irxreminder.com
Fred Ma, M.D., Ph.D.
CONTACT
2164695725
fma@irxreminder.com

Principal Investigator

Rakesh Ranjan, M.D.
STUDY_DIRECTOR
Charak Research Center
Owen Muir, M.D.
STUDY_DIRECTOR
Fermata Health

Study Locations (Sites)

Fermata Helath
Brooklyn, New York, 10038
United States
Charak Research Center
Garfield Heights, Ohio, 44125
United States

Collaborators and Investigators

Sponsor: iRxReminder

  • Rakesh Ranjan, M.D., STUDY_DIRECTOR, Charak Research Center
  • Owen Muir, M.D., STUDY_DIRECTOR, Fermata Health

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2023-05-30
Study Completion Date2024-12-31

Study Record Updates

Study Start Date2023-05-30
Study Completion Date2024-12-31

Terms related to this study

Additional Relevant MeSH Terms

  • Tardive Dyskinesia